As of 2026-03-27, the Relative Valuation of Britannia Life Sciences Inc (BLAB.CN) is 0.09 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.09 CAD, the upside of Britannia Life Sciences Inc based on Relative Valuation is -1.8%.
The range of the Relative Valuation is 0.09 - 0.09 CAD.
| Range | Selected | |
| Trailing P/E multiples | 1.3x - 1.3x | 1.3x |
| Forward P/E multiples | 1.3x - 1.3x | 1.3x |
| Fair Price | 0.09 - 0.09 | 0.09 |
| Upside | -1.8% - -1.8% | -1.8% |
| Date | P/E |
| 2026-03-23 | 1.32 |
| 2026-03-20 | 1.40 |
| 2026-03-19 | 1.40 |
| 2026-03-18 | 1.40 |
| 2026-03-17 | 1.40 |
| 2026-03-16 | 1.40 |
| 2026-03-12 | 1.40 |
| 2026-03-11 | 1.47 |
| 2026-03-10 | 1.47 |
| 2026-03-09 | 1.47 |
| 2026-03-06 | 1.62 |
| 2026-03-05 | 1.47 |
| 2026-03-04 | 1.55 |
| 2026-03-03 | 1.55 |
| 2026-02-27 | 1.47 |
| 2026-02-26 | 1.40 |
| 2026-02-25 | 1.47 |
| 2026-02-23 | 1.47 |
| 2026-02-20 | 1.47 |
| 2026-02-18 | 1.47 |
| 2026-02-17 | 1.47 |
| 2026-02-11 | 1.47 |
| 2026-02-10 | 1.47 |
| 2026-02-09 | 1.47 |
| 2026-02-05 | 1.47 |
| 2026-02-03 | 1.47 |
| 2026-02-02 | 1.47 |
| 2026-01-29 | 1.55 |
| 2026-01-28 | 1.47 |
| 2026-01-27 | 1.40 |
| 2026-01-26 | 1.40 |
| 2026-01-23 | 1.18 |
| 2026-01-21 | 1.18 |
| 2026-01-20 | 1.10 |
| 2026-01-19 | 1.18 |
| 2026-01-16 | 1.18 |
| 2026-01-14 | 1.18 |
| 2026-01-13 | 1.18 |
| 2026-01-12 | 1.18 |
| 2026-01-09 | 1.18 |
| 2026-01-08 | 1.18 |
| 2026-01-07 | 1.25 |
| 2026-01-06 | 1.18 |
| 2026-01-05 | 1.32 |
| 2026-01-02 | 1.32 |
| 2025-12-31 | 1.32 |
| 2025-12-30 | 1.32 |
| 2025-12-29 | 1.32 |